Nautilus Biotechnology, Inc. (NAUT)
NASDAQ
3.24
+0.64 (+24.62%)
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
2.573.26
52 wk Range
0.84104.31
Financial Statements - NAUT - Nautilus Biotechnology, Inc.
Revenue
0
Net Income
-59.00M▲ 16.6%
EBITDA
-60.37M▲ 19.6%
Free Cash Flow
-51.97M▲ 15.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -66.83M | -81.47M | -76.15M | -63.61M | -50.49M | -15.74M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -32K | -84K | -73K | -122K | -146K | 125K |
| Pre Tax Income | -59M | -70.78M | -63.67M | -57.92M | -50.31M | -15.61M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -59M | -70.78M | -63.67M | -57.92M | -50.31M | -15.61M |
| EPS Basic | -0.47 | -0.56 | -0.51 | -0.46 | -0.6 | -0.125914 |
| EPS Diluted | -0.47 | -0.56 | -0.51 | -0.46 | -0.6 | -0.125914 |
| Basic Shares Outstanding | 126.25M | 125.42M | 124.91M | 124.58M | 84.46M | 124.04M |
| Diluted Shares Outstanding | 126.25M | 125.42M | 124.91M | 124.58M | 84.46M | 124.04M |
| Ebit | -66.83M | -81.47M | -76.15M | -63.61M | -50.49M | -15.74M |
| Ebitda | -60.37M | -75.12M | -70.44M | -60.20M | -47.65M | -13.39M |
| Net Income Continuous Operations | -59M | -70.78M | -63.67M | -57.92M | -50.31M | -15.61M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
